InvestorsHub Logo

TheDane

10/30/18 9:51 PM

#246892 RE: DaubersUP #246889

But that’s fully developed and ready for the market. Net present value is more interesting. $3 billion might be high but certainly $1 to 2 billion will entice many sellers. I’ve already stated I’ll sell 20% of my shares at the first $billion. (Dane, Dane, wake up, Dane. You’re dreaming again.)

Go IPIX!

Amatuer17

10/31/18 2:13 AM

#246898 RE: DaubersUP #246889

K has not shown efficacy yet - activating P53 does not mean cancer cure even if P53 is activated. It is still pipe dream.

In the meantime others are coming with better cancer cell killer code

Cellular kill code discovery may help extinguish cancers https://newatlas.com/cancer-cell-kill-code-sirna-northwestern/57036/

Empiricst1

10/31/18 1:57 PM

#246964 RE: DaubersUP #246889

DauberUP, I actually believe the company re the $30 million price tag as being too high right now. I have long believed that since Brilacidin can treat MDRs that a pill, or at least an injection should be available, not just an iv or a topical. After reviewing it all once again it occurs to me that there are too many good reasons why a pill will not happen (too bad, as that would be where the real money was), there must be trouble with injections of which the company has not been specific about, and there is the very effective iv use, though this will not lead to the huge profits otherwise available. I've asked the compony why no injection and never got answered, so figure there is a good reason, though I do feel a fair question deserves a fair response, given that there is not apparent reason why this should be secret. Who knows. There has been wise speculation here why an injection is not going to be available, but I would like an answer some day, after all, there is real money riding on it (mine and ours). So, after all this, I don't think the ABSSSI use will be a billion dollar drug, just a good profit maker. I just can't believe a hospital/facility iv treatment for skin issues will be that huge. On this I could be really wrong, and I hope I am.